Disclosures for "Smoking-related Genomic Alterations Are Observed in Patients with Glioma and May Contribute to Shortened Survival"
-
Ms. Landry has nothing to disclose.
-
Ms. Bognet has nothing to disclose.
-
Ms. Ahr has nothing to disclose.
-
Dr. Ramkissoon has received personal compensation for serving as an employee of Labcorp. Dr. Ramkissoon has stock in Labcorp.
-
Michael Chan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biomimetix. Michael Chan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Monteris.
-
Christina Cramer has nothing to disclose.
-
The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
-
Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris .
-
Dr. White has nothing to disclose.
-
Ryan Mott has nothing to disclose.
-
Dr. Stogner has nothing to disclose.
-
Dr. Severson has received personal compensation for serving as an employee of Labcorp.
-
Dr. Wallen has received personal compensation for serving as an employee of Labcorp.
-
Fang-Chi Hsu has nothing to disclose.
-
Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cancer Expert Now. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SDP Oncology. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incysus . Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharma. Glenn Lesser has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Glenn Lesser has received research support from Denovo Biopharma. The institution of Glenn Lesser has received research support from Oblato . The institution of Glenn Lesser has received research support from Novocure. The institution of Glenn Lesser has received research support from GBM Agile - GCAR.
-
Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.